Jim Cramer Says Worldwide Drug Sales Are Driving J&J’s Business
Jim Cramer says J&J's latest quarterly report highlights strong sales of prescription drugs globally.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said J&J's (JNJ) - Get Report latest quarterly report highlights strong sales of prescription drugs globally. Cramer said worldwide drugs are driving the company's growth, especially sales of its Imbruvica drug. Cramer also urged investors to remember that J&J has ten drugs in its pipeline that could each be worth at least a billion dollars.
At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.
